Not applicableNot Yet RecruitingNCT07724886What this trial is testingRole of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBCWho this might be right forBladder Cancer Chinese University of Hong Kong 732
Early research (Phase 1)Study completedNCT01303991What this trial is testingHexvix Photodynamic Therapy in Patients With Bladder CancerWho this might be right forIntermediate or High-risk Bladder Cancer Photocure 17
Testing effectiveness (Phase 2)Looking for participantsNCT06971614What this trial is testingT3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBCWho this might be right forNonmuscle-invasive Bladder Cancer ImmVira Pharma Co. Ltd 160
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Not applicableLooking for participantsNCT04564781What this trial is testingPredicting BCG ResponseWho this might be right forBladder Cancer Cedars-Sinai Medical Center 400
Testing effectiveness (Phase 2)Looking for participantsNCT06678126What this trial is testingAdaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)Who this might be right forProstate Cancer Scott Tyldesley 104